KORU Medical Systems IncKRMD
Price$2.96

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $45.1M+34.1% YoYTTM through 30 Jun 2026
Net Income -$1.8MTTM through 30 Jun 2026
Free Cash Flow $776.7KTTM through 30 Jun 2026

Margins

Current
Gross Margin61.5%
EBITDA Margin-1.9%
Operating Margin-7.4%
Net Margin-4.0%

Returns

-13.7%ROE
-8.0%ROA

Balance Sheet Health

Debt / Equity0.01x
Current Ratio2.33x
Net Debt-$8.6Mnet cash position
Cash & Equivalents$8.3M

Quality Metrics

Altman Z-Score9.57
Piotroski F-Score5 / 9
FCF Margin1.7%
Rule of 409.7
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $41.1M
Diluted EPS-$0.04TTM
'19'20'21'22'23'24'25
FY2025: $-0.06

Dividend

No dividend

Capital Allocation

R&D Spend$4.5M
Capex Intensity1.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.